|
Product name
|
Telmisartan Intermediate 152628-03-0
4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid
|
|
Molecular Formula
|
C12H14N2O2
|
|
Molecular Weight
|
218.25
|
|
CAS No.
|
152628-03-0
|
|
Quality Standard
|
99% up by HPLC,
medical grade
|
|
Appearance
|
White powder
|
|
COA of Amikacin Intermediate 40371-50-4
|
|
Items
|
Specifications
|
Results
|
|
Appearance
|
Off-white to white powder
|
Off-white powder
|
|
Identification (HPLC)
|
Must conform to reference standard
|
Conforms
|
|
Sulfated Ashes
|
≤0.30%
|
0.06%
|
|
Water by KF
|
≤0.5%
|
0.04%
|
|
Any Single Impurity
|
≤0.25%
|
0.11%
|
|
Purity (by HPLC)
|
≥99.0%
|
99.80%
|
|
Conclusion
|
Conforms with the enterprise standard.
|
4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid with its CAS No.: 152628-03-0 is a key intermediate of Telmisartan (Cardiovescular Medicine). Telmisartan is used in the
treatment of adult essential hypertension. Reduces cardiovascular style This
product is suitable for patients aged 55 years and older. Patients with high
risk of serious cardiovascular events and who are unable to receive
angiotensin-converting enzyme (ACE) inhibitors to reduce myocardial infarction,
stroke or heart Vascular disease leads to the risk of death.
